BioNexus Gene Lab Corp. (BGLC) Capital expenditures 2018–2025
BioNexus Gene Lab Corp. (BGLC) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$36,971FY2025 · since FY2018: $39,621 → $36,971
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $36,971 | -83.7% |
| FY2024 | $226,989 | +51.9% |
| FY2023 | $149,398 | — |
| FY2022 | $0 | -100.0% |
| FY2021 | $3,162 | -99.3% |
| FY2020 | $421,621 | +3189.5% |
| FY2019 | $12,817 | -67.7% |
| FY2018 | $39,621 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice